SD
Srikripa Devarakonda Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.6%
Neutral
17.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $35 |
3%
downside
| 2 | +0.45% |
0
%
| 11 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $55 |
20%
upside
| 2 | +25% |
0
%
| 4 Mar ‘26 3 months ago |
|
|
|
Hold
Maintained
| $193 |
3%
downside
| 3 | +57% |
0
%
| 9 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $92 |
29%
upside
| 1 | -8.7% |
0
%
| 3 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $110 |
2%
downside
| 2 | +13% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $116 |
36%
upside
| 3 | +14% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $56 |
6%
upside
| 4 | +58% |
0
%
| 9 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $640 |
28%
upside
| 2 | +4.3% |
0
%
| 19 Nov ‘25 6 months ago |
|
|
|
Hold
Reiterated
| $93 |
9%
downside
| 4 | – |
–
| 29 Oct ‘25 7 months ago |
|
|
|
Buy
Initiated
| $15 |
8%
downside
| 1 | +37% |
0
%
| 15 Oct ‘25 8 months ago |
|
|
|
Buy
Initiated
| $50 |
28%
upside
| 1 | +123% |
0
%
| 15 Oct ‘25 8 months ago |
|
|
|
Buy
Maintained
| $812 |
32%
upside
| 3 | +10% |
0
%
| 11 Aug ‘25 10 months ago |
|